======= RABGEF1 ======= == Gene Information == * **Official Symbol**: RABGEF1 * **Official Name**: RAB guanine nucleotide exchange factor 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27342|27342]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UJ41|Q9UJ41]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RABGEF1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RABGEF1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609700|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Rab effector protein acting as linker between gamma- adaptin, RAB4A or RAB5A. Involved in endocytic membrane fusion and membrane trafficking of recycling endosomes. Stimulates nucleotide exchange on RAB5A. Can act as a ubiquitin ligase (By similarity). {ECO:0000250, ECO:0000269|PubMed:11452015, ECO:0000269|PubMed:15339665, ECO:0000269|PubMed:9323142}. |zf-A20| |VPS9| |negative regulation of Kit signaling pathway| |regulation of Kit signaling pathway| |negative regulation of mast cell degranulation| |negative regulation of mast cell activation involved in immune response| |negative regulation of myeloid leukocyte mediated immunity| |negative regulation of interleukin-6 secretion| |regulation of Fc receptor mediated stimulatory signaling pathway| |negative regulation of leukocyte degranulation| |negative regulation of mast cell activation| |negative regulation of receptor-mediated endocytosis| |negative regulation of regulated secretory pathway| |negative regulation of exocytosis| |regulation of mast cell degranulation| |regulation of mast cell activation involved in immune response| |Rab guanyl-nucleotide exchange factor activity| |negative regulation of interleukin-6 production| |negative regulation of endocytosis| |regulation of mast cell activation| |negative regulation of leukocyte migration| |negative regulation of leukocyte mediated immunity| |regulation of leukocyte degranulation| |negative regulation of Ras protein signal transduction| |regulation of myeloid leukocyte mediated immunity| |negative regulation of small GTPase mediated signal transduction| |negative regulation of intracellular transport| |negative regulation of cytokine-mediated signaling pathway| |negative regulation of response to cytokine stimulus| |negative regulation of cytokine secretion| |regulation of receptor-mediated endocytosis| |recycling endosome| |negative regulation of immune effector process| |negative regulation of protein secretion| |negative regulation of inflammatory response| |negative regulation of peptide secretion| |regulation of interleukin-6 production| |negative regulation of immune response| |Rab GTPase binding| |early endosome membrane| |protein targeting to membrane| |regulation of cytokine-mediated signaling pathway| |regulation of regulated secretory pathway| |negative regulation of leukocyte activation| |regulation of response to cytokine stimulus| |negative regulation of protein transport| |negative regulation of establishment of protein localization| |regulation of leukocyte migration| |negative regulation of cell activation| |negative regulation of secretion by cell| |regulation of cytokine secretion| |regulation of endocytosis| |regulation of leukocyte mediated immunity| |negative regulation of defense response| |positive regulation of immune effector process| |ubiquitin protein ligase activity| |regulation of exocytosis| |negative regulation of secretion| |regulation of Ras protein signal transduction| |early endosome| |negative regulation of cell migration| |establishment of protein localization to membrane| |negative regulation of cytokine production| |negative regulation of cell motility| |negative regulation of cellular component movement| |negative regulation of locomotion| |regulation of inflammatory response| |regulation of small GTPase mediated signal transduction| |regulation of intracellular transport| |protein targeting| |negative regulation of response to external stimulus| |negative regulation of protein phosphorylation| |negative regulation of immune system process| |negative regulation of phosphorylation| |regulation of protein secretion| |regulation of immune effector process| |protein localization to membrane| |negative regulation of transport| |regulation of peptide secretion| |negative regulation of intracellular signal transduction| |regulation of vesicle-mediated transport| |endocytosis| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |regulation of leukocyte activation| |regulation of cell activation| |import into cell| |protein ubiquitination| |regulation of cytokine production| |negative regulation of cellular component organization| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of defense response| |protein modification by small protein conjugation| |regulation of secretion| |zinc ion binding| |regulation of cell migration| |nucleolus| |regulation of cell motility| |regulation of cellular localization| |regulation of locomotion| |protein modification by small protein conjugation or removal| |intracellular protein transport| |regulation of cellular component movement| |regulation of protein localization| |negative regulation of cellular protein metabolic process| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |positive regulation of immune system process| |regulation of immune response| |negative regulation of multicellular organismal process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |regulation of protein phosphorylation| |DNA binding| |regulation of response to stress| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |establishment of protein localization| |negative regulation of response to stimulus| |regulation of immune system process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |establishment of localization in cell| |regulation of protein modification process| |nitrogen compound transport| |regulation of transport| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp453|B02 10μM R08 exp453]]|-2.6| |[[:results:exp245|UM0011500 5μM R05 exp245]]|-2.27| |[[:results:exp432|YM155 0.001μM R08 exp432]]|-2.12| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.07| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-1.98| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.95| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|-1.92| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-1.8| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.78| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|2.07| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|2.2| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.34| ^Gene^Correlation^ |[[:human genes:a:aagab|AAGAB]]|0.411| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6975 * **Expression level (log2 read counts)**: 5.18 {{:chemogenomics:nalm6 dist.png?nolink |}}